Clinical Studies

Caring for our patients is our biggest priority. Our clinics offer expert services in several specialized areas of genetics. 

Angelman Syndrome Study

Ovid Therapeutics is sponsoring a clinical research study called the STARS study. The STARS study will evaluate the safety and effectiveness of an investigational medicine on various aspects associated with Angelman syndrome. The STARS study will enroll approximately 75 people in a Phase 2 double-blind placebo-controlled randomized study.

Fragile X Syndrome Program

Fragile X syndrome (FXS) is a genetic condition that causes intellectual disability, behavioral and learning challenges and various physical characteristics. Though FXS occurs in both genders, males are more frequently affected than females, and generally with greater severity

Longitudinal Studies of the Glycoproteinoses

This project seeks to obtain clinical and laboratory information about individuals affected with a glycoprotein storage disorder including aspartyglucosaminuria, fucosidosis, galactosialidosis, alpha-mannosidosis, beta-mannosidosis, mucolipidosis II, mucolipidosis III, Schindler disease, and sialidosis.

Rett Syndrome Program

Through clinical care, research, and advocacy, the Rett Syndrome and Related Disorders Program of the Greenwood Genetic Center dedicated to the benefit of all individuals and families impacted by these conditions.

Lucy's Story

Lucy's Story

When our daughter Lucy had a metabolic crisis at 7 days old, we were shocked and devastated to find out that she was born with a rare genetic disorder (MSUD). Her newborn screening results did not make it back in time to prevent the crisis, and no one at our local hospital was familiar with the disease. They did not know how to treat her. Calls were made to Greenwood Genetic Center to confirm her diagnosis...

In The News